KalVista Pharmaceuticals (KALV) Current Leases (2017 - 2024)
Historic Current Leases for KalVista Pharmaceuticals (KALV) over the last 7 years, with Q4 2024 value amounting to $1.5 million.
- KalVista Pharmaceuticals' Current Leases changed N/A to $1.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.5 million, marking a year-over-year change of. This contributed to the annual value of $1.3 million for FY2024, which is N/A changed from last year.
- KalVista Pharmaceuticals' Current Leases amounted to $1.5 million in Q4 2024.
- In the past 5 years, KalVista Pharmaceuticals' Current Leases registered a high of $1.5 million during Q4 2024, and its lowest value of $422000.0 during Q4 2020.
- Its 4-year average for Current Leases is $976583.3, with a median of $1.1 million in 2023.
- Data for KalVista Pharmaceuticals' Current Leases shows a peak YoY increase of 98888.89% (in 2020) and a maximum YoY decrease of 2990.03% (in 2020) over the last 5 years.
- KalVista Pharmaceuticals' Current Leases (Quarter) stood at $422000.0 in 2020, then soared by 40.28% to $592000.0 in 2021, then soared by 93.92% to $1.1 million in 2023, then rose by 26.48% to $1.5 million in 2024.
- Its last three reported values are $1.5 million in Q4 2024, $1.5 million for Q4 2024, and $1.3 million during Q3 2024.